Pfizer quits Duchenne gene therapy, lays off staff following study setback
Bio Pharma Dive
JULY 30, 2024
The company is letting go of 150 staffers alongside a decision to officially terminate the high-profile program, which was acquired in 2016.
Tue.Jul 30, 2024
340 
Study finds semaglutide decreases tobacco-related healthcare
Pharmaceutical Technology
JULY 30, 2024
Semaglutide, marketed as Ozempic and Wegovy, decreased tobacco-related healthcare encounters compared to other medications.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Ancient Genes of Zombie Viruses Revealed as Hidden Drivers of Cancer
AuroBlog - Aurous Healthcare Clinical Trials blog
JULY 30, 2024
When viruses pay us a visit, they sometimes leave parts of themselves behind. Silently tucked away in our genomes, some of these bits of foreign DNA can get passed down through the generations.
GSK and Flagship Pioneering link for new medicines and vaccines
Pharmaceutical Technology
JULY 30, 2024
GSK has announced a strategic collaboration with Flagship Pioneering for the discovery and development of medicines and vaccines.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pfizer’s Bourla confident in company’s obesity drug position, despite delays
Bio Pharma Dive
JULY 30, 2024
The CEO noted how Pfizer's danuglipron could still be the second oral GLP-1 treatment to enter registrational tests after Lilly's orforglipron.
Collegium buys Ironshore for $525m and enter ADHD market
Pharmaceutical Technology
JULY 30, 2024
Collegium will pay $525m upfront to add Ironshore’s FDA-approved ADHD medication Jornay PM to its portfolio.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Ventyx scraps TYK2 inhibitor after Phase II Crohn’s defeat
Pharmaceutical Technology
JULY 30, 2024
Ventyx no longer plans to conduct additional clinical trials of VTX958 with internal resources after the Phase II trial missed its primary endpoint.
July 30, 2024: Save the Date: Meet HCRSN in St. Louis for the 2025 Annual Conference
Rethinking Clinical Trials
JULY 30, 2024
The Health Care Systems Research Network (HCSRN) will hold its 2025 Annual Conference from April 8 to 10, 2025, in St. Louis, Missouri. HCSRN is a 20-member research network focused on supporting research institutes aligned with healthcare delivery systems. HCSRN’s mission is to improve individual and population health through research that connects the resources and capabilities of learning healthcare systems.
Biotech IPO raising in Q1 2024 surged from Q4 2023 – but has the momentum lasted?
Pharmaceutical Technology
JULY 30, 2024
Biotech IPOs surged in Q1 2024, with eight completed IPOs raising a total of $3.72bn, six times more than the $621m raised in Q4 2023.
Talk of the Towne episode 11: American Kidney Fund
Antidote
JULY 30, 2024
In the latest installment of Talk of the Towne, we sat down with Melanie Paris, M.A., MPH, the Senior Director of Strategic Partnerships and Kidney Disease Education at the American Kidney Fund (AKF). In the discussion, we got her insights into the types of kidney disease, treatment disparities, and the importance of clinical research in the field. She also shared many valuable resources for individuals and their loved ones living with kidney disease, which are linked here.
Roche’s Vabysmo challenges Eylea dominance with third European indication
Pharmaceutical Technology
JULY 30, 2024
The European Commission (EC) has approved Vabysmo (faricimab) for the treatment of retinal vein occlusion.
Pfizer tacks on $1B to 2024 revenue outlook amid cost-cutting drive
Fierce Pharma
JULY 30, 2024
For more than a year after Pfizer’s COVID product sales peaked at the end of 2022, the company’s quarterly revenues showed year-over-year declines. | For the first time since its sales peaked during the pandemic, Pfizer registered year-over-year revenue growth during the second quarter of 2024. And while the busy has been busy trimming operating expenses, it did add $1 billion to its total revenue projection for the year.
Boehringer Ingelheim acquires Nerio Therapeutics for $1.3bn
Pharmaceutical Technology
JULY 30, 2024
Boehringer Ingelheim has acquired Nerio Therapeutics, a drug discovery and development company, in a deal valued at $1.3bn.
A symbiotic relationship for optimal AI-powered healthcare
pharmaphorum
JULY 30, 2024
Discover how OPEN Health and fusion's AI technology partnership is creating a symbiotic relationship that is revolutionising healthcare. Explore the benefits of this for optimal patient care.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
NICE not to recommend Daiichi Sankyo-AstraZeneca’s Enhertu for NHS
Pharmaceutical Technology
JULY 30, 2024
The UK NICE has decided not to recommend Daiichi Sankyo and AstraZeneca’s Enhertu for advanced HER2-low breast cancer for NHS use.
5 cybersecurity guidelines for remote monitoring in clinical trials
pharmaphorum
JULY 30, 2024
Implementing strong cybersecurity guidelines for remote monitoring in clinical trials is crucial to protect sensitive data. Learn these top 5 guidelines to secure your remote monitoring plan effectively.
FDA grants priority review for Novartis’ leukaemia treatment
Pharmaceutical Technology
JULY 30, 2024
The US FDA has granted priority review designation for Novartis’ Scemblix for Ph-positive chronic myeloid leukemia in the chronic phase.
Approaching the regulatory world with passion: CERs and EU MDR processes
pharmaphorum
JULY 30, 2024
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Ethan Drower, co-founder and CEO of Cite Medical Solutions, a company providing full Clinical Evaluation Report (CER) services and industry literature review for European Union Medical Device Regulation (or EU MDR) processes.
Cybersecurity in clinical trials: safeguarding patient data against digital breaches
Pharmaceutical Technology
JULY 30, 2024
Trials and their partners need to adopt a strong cybersecurity strategy to protect sensitive patient data from hackers.
HDR UK and DPUK granted £2m for new motor neurone disease research initiative
Pharma Times
JULY 30, 2024
The rapidly progressive neurological condition affects around 5,000 people in the UK
Pharma Pulse 7/30/24: The Doctor Will See You Now, But AI May Be Listening In.The Importance of Genomic Sequencing in the Battle Against HIV in South Africa & more
Pharmaceutical Commerce
JULY 30, 2024
The latest news for pharma industry insiders.
Older GLP-1 drug shows glimmer of benefit in Alzheimer's
pharmaphorum
JULY 30, 2024
A small study of Novo Nordisk's once-daily injectable GLP-1 agonist liraglutide shows a benefit in patients with Alzheimer's disease
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Benefits of Drug Patent Licensing Agreements
Drug Patent Watch
JULY 30, 2024
The Power of Patent Licensing: Unlocking Innovation and Access to Medicines Patent licensing agreements have become a crucial tool in the pharmaceutical industry, allowing companies to collaborate and…
Sanofi sues Sarepta, claiming Duchenne gene therapy Elevidys infringes 2 manufacturing patents
Fierce Pharma
JULY 30, 2024
Six months after surviving a patent challenge involving its $3.2 million gene therapy, Sarepta faces a new lawsuit from another gene therapy developer claiming the approved treatment infringes its | Six months after surviving a patent challenge involving its $3.2 million gene therapy, Sarepta faces a new lawsuit from another gene therapy developer claiming the approved treatment infringes active patents.
BioNTech cancer vaccine hits the spot in melanoma
pharmaphorum
JULY 30, 2024
mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma.The study is looking at the combination of BNT111 with Regeneron's PD-1 inhibitor Libtayo (cemiplimab) in 184 patients with advanced melanoma who have relapsed after or not responded to treatment with a PD-1/PD-L1 inhibitor, or the two therapies given alone.
Circular RNA Will Soon Replace mRNA in Biopharma
BioSpace
JULY 30, 2024
The advantages of using circular RNAs—including increased durability, enhanced protein expression, and substantially lower manufacturing costs compared to linear mRNAs—have driven a spate of investment in this technology.
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Boehringer buys oncology player Nerio in $1.3bn deal
pharmaphorum
JULY 30, 2024
Boehringer buys Nerio Therapeutics for $1.
Salmonella Control: Comparing US and EU Regulations for Poultry
XTalks
JULY 30, 2024
Salmonella control in poultry in the US has come under intense regulatory scrutiny over the past few years. With increasing concerns about food safety, it might be worth considering whether the US should adopt the European Union’s (EU) regulatory mindset. The US Department of Agriculture’s (USDA) Food Safety and Inspection Service (FSIS) declared Salmonella an adulterant in raw breaded stuffed chicken products when contamination levels exceed one colony-forming unit (CFU) per gram.
Study reveals new insights into ‘gene misbehaviour’ in healthy populations
Pharma Times
JULY 30, 2024
The findings could support investigations into human genetics and various complex diseases
Women in Science - Tehmina Masud - the importance of growing outside your comfort zone
BioPharma Reporter
JULY 30, 2024
A book, a computer and some sage words from her physicist father set Tehmina on her path to a successful career in science.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Let's personalize your content